Cell line · CVCL_3791
RWPE-1
Transformed cell line, Homo sapiens. 63 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. RWPE-1. Cell lines, record CVCL_3791. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_3791
On this page
Cell line
As Cellosaurus gives it.
- Name
- RWPE-1
- Accession
- CVCL_3791
- RRID
- RRID:CVCL_3791
- Synonyms
- RWPE1
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 54Y
- Category
- Transformed cell line
- Derived from
- Prostate, epithelium (in situ)
- Cell type
- Epithelial cell of prostate
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers63
5 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| The VCPIP1-UBE3A Deubiquitination-Ubiquitination Cascade Contributes to Castration-Resistant Prostate Cancer Progression. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Castration-resistant prostate cancer cells are addicted to the high activity of cyclin-dependent kinase 2. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| SLPI is associated with AR-regulated epithelial adaptation and enzalutamide sensitivity in castration-resistant prostate cancer. | Front Pharmacol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| ERG Orchestrates a Dedifferentiation-Senescence-Inflammation Triad in Prostate Cancer. | Mol Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Spatial and single-cell transcriptomics reveal a HIF-1α/NF-κB-driven hypoxia-induced senescence axis in BPH epithelium. | Int J Biol Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Impaired vitamin D signaling reveals neutrophils as key drivers of prostate cancer dissemination. | EMBO Mol Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting FANCD2 to overcome enzalutamide resistance in prostate cancer. | Cancer Metab | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Dynamic Shifts in ER-Plasma Membrane Junctions Signaling Define Pro-Metastatic N-Glycosylation and Predict Prostate Cancer Progression. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| OGDHL Promotes Prostate Cancer Progression and Regulates Neuroendocrine Marker Expression and Nucleotide Abundance. | Mol Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A smart gene circuit for precise regulation of tumor cell behavior. | Synth Syst Biotechnol | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 63
See all 63 papersRelatives9
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | CTPE | CVCL_4794 | Cell lines | |
| Derived from it | RWPE-2 | CVCL_3792 | Cell lines | |
| Derived from it | WPE-int | CVCL_K282 | Cell lines | |
| Derived from it | WPE-stem | CVCL_K283 | Cell lines | |
| Derived from it | WPE1-NA22 | CVCL_3810 | Cell lines | |
| Derived from it | WPE1-NB11 | CVCL_3811 | Cell lines | |
| Derived from it | WPE1-NB14 | CVCL_3812 | Cell lines | |
| Derived from it | WPE1-NB26 | CVCL_3813 | Cell lines | |
| From the same person | WPMY-1 | CVCL_3814 | Cell lines |
Cell banks5
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-11609 | Discontinued | Cellosaurus |
| ATCC | CRL-3607 | ATCC | |
| BCRJ | 0389 | BCRJ | |
| CCTCC | GDC0178 | Cellosaurus | |
| CLS | 305217 | CLS |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_3791
GET https://conductscience.org/api/cell-lines/v1/CVCL_3791/papers?page=2